Smart wearables and blood markers could spot Parkinson's years before symptoms worsen
NCT ID NCT07679256
First seen Jul 01, 2026 · Last updated Jul 01, 2026
Summary
This study aims to find better ways to diagnose Parkinson's disease in its earliest stages. Researchers will use wearable devices to track movement and analyze blood samples for specific markers from nerve cells. By combining these digital and biological clues, they hope to create a model that can identify Parkinson's before typical symptoms become severe. The study includes people with early Parkinson's, those with prodromal signs (like sleep disorders), and healthy volunteers.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could enable earlier detection of Parkinson's disease, potentially allowing treatment to start sooner and slow progression.
What could go wrong
This is an observational study developing a diagnostic model, not a treatment trial. The model may not prove accurate enough for clinical use, and results may not apply to all populations.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE (DISORDER) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Department of Neurology, Fujian Institute of Geriatrics, Fujian Medical University Union Hospital
RECRUITINGFuzhou, Fujian, 350000, China
Contact Phone: •••-•••-••••